Principal Development Leader for Companion Diagnostics (CDx), Oncology Biomarker Development @ (January 2015 - March 2023)
Senior Scientific Researcher, Oncology Biomarker Development @ (November 2011 - January 2015)
Department of Medicine - Research Specialist @ (January 2009 - November 2011)
Department of Pediatrics - Research Associate I and II @ (August 2004 - August 2007)
Doris Kim Education
University of California, Berkeley
B.A.
2000-2004
San Francisco State University
Post-Baccalaureate
Doris Kim Skills
Flow Cytometry
Immunoprecipitation
Subcloning
Molecular Cloning
Mutagenesis
DNA analysis
GraphPad Prism
Western Blotting
Primer Design
Sequence Analysis
Cell Signaling
Apoptosis
Signal Transduction
Biomarkers
Translational Medicine
Leukemia
Therapeutics
Pharmacogenomics
Stem Cells
qPCR
pre-clinical models
Biomarker Development
Companion Diagnostic Development
Cell Biology
In Vivo
Biochemistry
Clinical Trials
Cancer
Assay Development
Molecular Biology
Cancer Therapeutics
Genetics
Oncology
Life Sciences
Biotechnology
Clinical Development
Translational Research
Clinical Research
Drug Development
Immunohistochemistry
Polymerase Chain Reaction (PCR)
DNA Sequencing
Molecular Diagnostics
Medical Diagnostics
Team Management
Cross-functional Team Leadership
Personalized Medicine
Hospitals
Pediatrics
Microsoft Office
Cross Functional Team Leadership
Polymerase Chain Reaction Pcr
Pre Clinical Models
Medicine
Polymerase Chain Reaction
Doris Kim Summary
Doris Kim, based in California, United States, is currently a Vice President, Translational Science and Companion Diagnostics at Zentalis Pharmaceuticals. Doris Kim brings experience from previous roles at Zentalis Pharmaceuticals and Genentech. Doris Kim holds a 2000 - 2004 B.A. @ University of California, Berkeley. With a robust skill set that includes Flow Cytometry, Immunoprecipitation, Subcloning, Molecular Cloning, Mutagenesis and more. Doris Kim has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Doris Kim?
Find contact details for 700 million professionals.